Q2 EPS Estimates for The Cigna Group Decreased by Analyst

The Cigna Group (NYSE:CIFree Report) – Investment analysts at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of The Cigna Group in a note issued to investors on Monday, November 4th. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider will post earnings of $7.31 per share for the quarter, down from their prior estimate of $7.57. The consensus estimate for The Cigna Group’s current full-year earnings is $28.48 per share. Leerink Partnrs also issued estimates for The Cigna Group’s FY2026 earnings at $35.14 EPS, FY2027 earnings at $39.13 EPS and FY2028 earnings at $43.45 EPS.

CI has been the topic of several other reports. Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 price target (up from $392.00) on shares of The Cigna Group in a report on Tuesday. Jefferies Financial Group upped their target price on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Royal Bank of Canada reduced their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $394.64.

Get Our Latest Research Report on The Cigna Group

The Cigna Group Stock Up 1.9 %

CI stock opened at $318.34 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The firm’s fifty day simple moving average is $344.23 and its 200-day simple moving average is $340.99. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The company has a market capitalization of $88.55 billion, a P/E ratio of 30.03, a price-to-earnings-growth ratio of 0.96 and a beta of 0.51.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same period last year, the business posted $6.77 earnings per share. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.76%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s payout ratio is 52.83%.

Insiders Place Their Bets

In related news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Cedar Wealth Management LLC acquired a new position in shares of The Cigna Group during the 1st quarter valued at about $29,000. TruNorth Capital Management LLC purchased a new stake in shares of The Cigna Group in the 2nd quarter valued at approximately $33,000. Ulland Investment Advisors LLC increased its holdings in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group during the 3rd quarter valued at approximately $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in The Cigna Group in the second quarter valued at approximately $66,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

About The Cigna Group

(Get Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Earnings History and Estimates for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.